Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.
- 14 June 1975
- journal article
- Vol. 112, 80-2
Abstract
Trimethoprim-sulfamethoxazole (TMP-SMX) caused no significant changes in the blood glucose or insulin concentrations of diabetic subjects treated by dietary measures alone or by insulin and diet. In only one of eight subjects receiving oral hypoglycemic agents for the control of diabetes did a significant immediate increase in immunoreactive insulin follow administration of TMP-SMX. In the same patient hypoglycemic symptoms were present after the agent had been taken for 14 days.This publication has 6 references indexed in Scilit:
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963
- Protein interactions of sulfonylurea compounds.1962
- [The binding of long-acting sulfonamides on serum proteins. 2].1961
- [Potentiation of tolbutamide by phenylbutazone].1959
- CLINICAL AND EXPERIMENTAL STUDIES OF INSULIN SECRETION FOLLOWING TOLBUTAMIDE AND METAHEXAMIDE ADMINISTRATIONAnnals of the New York Academy of Sciences, 1959
- CHANGES INDUCED BY INSULIN AND TOLBUTAMIDE IN THE GLUCOSE OUTPUT OF THE LIVERAnnals of the New York Academy of Sciences, 1959